首页> 外文OA文献 >RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB

【2h】

RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB

机译：稀有24。成人反复压瘤的客观反应与临床益处：08-02核苷酸的最终报告：剂量 - 致粒粒子和拉帕替尼的II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Terri Armstrong; Ying Yuan; Jimin Wu; Tito Mendoza; Elizabeth Vera; Antonio Omuro; Frank Lieberman; H Robins; Elizabeth Gerstner; Jing Wu; Patrick Wen; Tom Mikkelsen; Kenneth Aldape; Mark Gilbert;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. A phase Ⅱ study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma [J] . Gilbert Mark R., Yuan Ying, Wu Jimin, Neuro-Oncology . 2021,第3期

机译：一种Ⅱ期对剂量 - 致密替替替替替替替替替替替替替替替替替替替替替替替替替替替替替换，脊髓脊髓突突瘤的研究
2. An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN) [J] . DeWire Mariko, Fouladi Maryam, Turner David C., Journal of neuro-oncology. . 2015,第1期

机译：贝伐单抗和拉帕替尼治疗复发性或难治性室管膜瘤患儿的开放标签，二阶段II期研究：一项协作性室管膜瘤研究网络研究（CERN）
3. A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311) [J] . Mitsuya Ishikawa, Kenichi Nakamura, Taro Shibata, Japanese journal of clinical oncology. . 2018,第12期

机译：常规紫杉醇和卡铂的随机期II / III试验，或没有贝伐单抗与剂量 - 致密紫杉醇和卡铂，在IVB期间，复发或持续的宫颈癌：日本临床肿瘤组研究（JCOG1311）
4. Minimally invasive treatment of Benign Prostatic Hyperplasia with High Intensity Focused Ultrasound using the Sonablate~(TM) System: an updated report of Phase III clinical studies conducted in the USA [C] . Thomas A. Gardner, Michael O Koch, Arieh Shalhav, Conference on Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems Ⅻ Jan 19-20, 22, 2002 San Jose, USA . 2002

机译：使用Sonablate〜（TM）系统以高强度聚焦超声微创治疗良性前列腺增生：在美国进行的III期临床研究的最新报告
5. RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB [O] . Terri Armstrong, Ying Yuan, Jimin Wu, -1

机译：稀有24。成人复发性表皮瘤的客观反应和临床获益：CERN 08-02的最终报告：剂量密集型替莫唑胺和拉帕替尼的II期研究
6. AT-07 * A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: PATIENT REPORTED OUTCOMES (PRO) FROM A CERN CLINICAL TRIAL [O] . T. S. Armstrong, E. Vera-Bolanos, M. Gilbert, 2014

机译：AT-07 *具有复发突瘤的成人的Lapatinib和剂量 - 粒子粒子（TMZ）的II期研究：患者报告了来自CERN临床试验的结果（Pro）

RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB

著录项

引文网络

相似文献

相关主题

期刊订阅